Why do we need to sell? So these great products can get to those who need them sooner rather than later. Neuren at the moment has little expertise in getting a drug through Phase 3, and the ASX is no place for a company with this potential to be. How many other great ASX listed success stories have there been in the biotech field? Oh, that's right. None. And for good reason. Sell and grow, or hold and wither. Take your pick.
Why do we need to sell? So these great products can get to those...
-
- There are more pages in this discussion • 1,903 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.00 |
Change
0.090(0.45%) |
Mkt cap ! $2.556B | |||
| Open | High | Low | Value | Volume |
| $19.88 | $20.07 | $19.73 | $11.80M | 591.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5901 | $19.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.00 | 3262 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |